Reply to "Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10%"

Cancer. 2023 Jul 1;129(13):2105. doi: 10.1002/cncr.34826. Epub 2023 Apr 27.

Authors

Ayat G Lashen¹, Michael S Toss¹, Emad A Rakha¹

Affiliation

¹ School of Medicine, University of Nottingham, Nottingham, UK.

PMID: 37106558
DOI: 10.1002/cncr.34826

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers, Tumor / metabolism
Breast Neoplasms*
Female
Humans
Progesterone
Receptor, ErbB-2 / metabolism
Receptors, Progesterone / metabolism

Substances

Receptors, Progesterone
Progesterone
Receptor, ErbB-2
Biomarkers, Tumor